ChromaDex Corp. (NASDAQ: CDXC) Starts Presentation at 5th Annual B. Riley FBR Consumer & Media Conference
ChromaDex (NASDAQ: CDXC) is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists’ partner with leading universities and research institutions worldwide to uncover the full potential of nicotinamide adenine dinucleotide (NAD), an essential molecule found in every living cell, and to identify and develop novel, science-based ingredients. Its flagship ingredient, NIAGEN® nicotinamide riboside, sold directly to consumers as TRU NIAGEN®, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN® is helping the world AGE BETTER®. For more information, visit the company’s website at www.chromadex.com. About NetworkNewsWire NetworkNewsWire (NNW) is…